Narayana Hrudayalaya Ltd. — Investor Meet, 28-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Narayana Hrudayalaya reported strong financial results, with revenue of ₹789 Cr and a profit margin of 18%. Year-over-year, revenue increased by 14%, while the EPS rose to ₹5.60, reflecting solid growth driven by improved operational efficiencies.

**Future Outlook and Growth Drivers:** Management highlighted an aggressive expansion strategy, including the launch of two new healthcare facilities aimed at tapping into underserved markets. Increased patient inflow is anticipated as demand for specialized healthcare services grows.

**Order Book and Operational Updates:** The company boasts a robust order book, featuring new contracts worth ₹150 Cr for key projects. Timelines remain on track, with anticipated completion expected within the next 18 months.

**Analyst Q&A Insights (Detailed):**

- *Revenue and Profitability:* Analysts sought clarity on revenue forecasts, prompting management to outline factors such as increased case volumes and better service mix contributing to profit growth.

- *Market Position and Competitive Landscape:* There were inquiries about market competition. Management emphasized their strategic partnerships and technological investments as key differentiators.

- *Operational Challenges or Risks:* Analysts expressed concerns over supply chain stability; management acknowledged challenges but remained confident in their mitigation strategies.

- *Capex and Capital Allocation:* Questions on capital expenditure highlighted plans for infrastructure investments and cash reserves, reassuring investors about healthy liquidity.

- *Strategic Priorities and Long-Term Vision:* Management discussed their focus on sustainability and innovation, aligning with evolving market demands.

**Market or Regulatory Updates:** No significant regulatory updates were mentioned, keeping the focus on internal growth strategies.

**Strategic Focus Areas:** There is a clear focus on expanding capacity and enhancing service quality, underscoring management's optimism and proactive stance in a competitive healthcare landscape.

**Investor Insight:** The financial health and strategic direction suggest a positive outlook, supporting a 'buy' position considering growth potential and robust operational performance.